Skip to content

Alpha Cognition ACOG Return on equity

Return on equity at other companies

Biogen logo
BiogenBIIB
8%-1.2pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
37.3%+0.1pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
18.8%+15.6pp
uniQure logo
uniQureQURE
-228.2%-11.6pp
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
-49.6%+34.2pp

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Current ratio12.6×-4.5×

Where this comes from

Calculated from Alpha Cognition’s reported figures.

Based on trailing twelve months.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's return on equity?
Alpha Cognition (ACOG) reported return on equity of -52.4% in Q1 2026.
How has Alpha Cognition's return on equity changed year-over-year?
Alpha Cognition's return on equity increased by 11.1% year-over-year, from -59% to -52.4%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.